Impact of moderate-to-severe coronary calcification on 1-year clinical outcomes after IVUS-guided PCI

Thanh Cong Nguyen1, Vu Hoang Vu1,2, Bao Thien Duong1

  • 1Interventional Cardiology Department, University Medical Center Ho Chi Minh City, Ho Chi Minh City, Vietnam.

PubMed

Insights

Moderate-to-severe coronary artery calcification (CAC) did not significantly impact 1-year outcomes after intravascular ultrasound (IVUS)-guided percutaneous coronary intervention (PCI). This suggests IVUS guidance may mitigate risks associated with calcified lesions.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Medical Imaging

Background:

  • Moderate-to-severe coronary artery calcification (CAC) presents challenges in percutaneous coronary intervention (PCI), historically linked to procedural failure and adverse outcomes.
  • The prognostic significance of severe CAC in the context of modern intravascular imaging-guided PCI is not well-established.

Purpose of the Study:

  • To assess the impact of moderate-to-severe CAC on 1-year clinical outcomes following intravascular ultrasound (IVUS)-guided PCI.
  • To determine if severe CAC remains an independent predictor of adverse events in the era of advanced PCI techniques.

Main Methods:

  • A prospective, single-center study included 914 patients undergoing IVUS-guided PCI.
  • Coronary artery calcification (CAC) severity was assessed using IVUS and categorized as none/mild or moderate-to-severe.
  • One-to-one propensity score matching created a cohort of 576 patients (288 per group) to compare outcomes.

Main Results:

  • Moderate-to-severe CAC was identified in 37.0% of patients.
  • Initially, 1-year major adverse cardiac events (MACE) were higher in the severe CAC group (9.5% vs. 4.2%, p=0.001).
  • After propensity score matching, the MACE difference was not statistically significant (9.4% vs. 6.3%, p=0.162), and severe CAC was not a significant predictor of MACE (HR 1.54; 95% CI 0.85-2.79; p=0.157).

Conclusions:

  • Routine IVUS-guided PCI is associated with comparable 1-year clinical outcomes for patients with moderate-to-severe CAC versus those with no or mild calcification.
  • Intravascular ultrasound guidance may effectively manage the risks associated with significant coronary calcification during PCI.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
572
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
321
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
324
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
454
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
750
Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
409